UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

Not Applicable

Completed

Conditions: Vasomotor Rhinitis

Interventions: Drug: placebo
Drug: esomeprazole

First Posted Date: 2008-09-03

Last Posted Date: 2019-06-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 43

Registration Number: NCT00745849

Locations: 🇺🇸
Clinical Trials Office, Aston Building, UT Southwestern, Dallas, Texas, United States

Impulsivity, Neural Deficits and Cocaine Addiction

Completed

Conditions: Cocaine Dependence

First Posted Date: 2008-09-01

Last Posted Date: 2013-01-03

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 90

Registration Number: NCT00744601

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Divison on Addictions, Dallas, Texas, United States

Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism

Completed

Conditions: Alcohol Dependence

First Posted Date: 2008-09-01

Last Posted Date: 2013-01-03

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 75

Registration Number: NCT00744588

Locations: 🇺🇸
UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty

Completed

Conditions: Corneal Edema Secondary to Corneal Endothelial Dystrophy

Interventions: Procedure: DSAEK
Diagnostic Test: Anterior Segment Optical Coherence Topography (OCT)
Diagnostic Test: Best Spectacle Corrected Visual Acuity (BSCVA)

First Posted Date: 2008-09-01

Last Posted Date: 2020-12-11

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 21

Registration Number: NCT00744796

Locations: 🇺🇸
UT Southwestern Medical Center - Aston Ambulatory Clinic, Dallas, Texas, United States

Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo

Phase 4

Completed

Conditions: Mild Gestational Diabetes

Interventions: Drug: Placebo
Drug: Glyburide

First Posted Date: 2008-09-01

Last Posted Date: 2020-03-12

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 395

Registration Number: NCT00744965

Locations: 🇺🇸
Parkland Memorial Hospital, Dallas, Texas, United States

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients

Completed

Conditions: Hepatitis C

First Posted Date: 2008-06-23

Last Posted Date: 2013-01-21

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 72

Registration Number: NCT00703560

Study on the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression

Not Applicable

Completed

Conditions: Painful Diabetic Neuropathy

Interventions: Procedure: Nerve Decompression

First Posted Date: 2008-06-23

Last Posted Date: 2015-05-28

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 138

Registration Number: NCT00703209

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Macrophage Inhibitory Factor and High-Mobility Group-1 Protein in Children Undergoing Cardiopulmonary Bypass

Completed

Conditions: Myocardial Depression

First Posted Date: 2008-06-06

Last Posted Date: 2017-05-10

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 30

Registration Number: NCT00692432

Locations: 🇺🇸
Children's Medical Center Dallas, Dallas, Texas, United States

Role of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in Children With Myocarditis

Completed

Conditions: Myocarditis

First Posted Date: 2008-06-06

Last Posted Date: 2008-06-06

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 36

Registration Number: NCT00693134

Locations: 🇺🇸
Children's Medical Center, Dallas, Texas, United States

Study to Demonstrate Cognitive Enhancing Effects of BF2.649

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: BF2.649

First Posted Date: 2008-06-04

Last Posted Date: 2019-04-23

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 52

Registration Number: NCT00690274

Locations: 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy